Loading...
PBF is not a good buy right now for an impatient investor. The chart trend is constructive (bullish moving averages and RSI not overbought), but options sentiment is notably defensive (put-heavy) and the statistical pattern outlook flags higher downside risk over the next month. With earnings coming 2026-02-12 (pre-market) and EPS expected to be negative (-0.15 est.), the near-term setup is not compelling enough to justify chasing an entry today.
Intellectia Proprietary Trading Signals
Pre-market is 32.87 (-1.17%) with SP500 -0.5% (risk-off tape). Trend/price structure remains bullish: SMA_5 > SMA_20 > SMA_200 implies a sustained uptrend. Momentum is positive but cooling: MACD histogram +0.285 and positively contracting (bullish, but losing thrust). RSI(6)=62.6 is neutral-to-slightly-bullish (not overbought).
Key levels: Pivot 32.386 is the first area to hold; losing it increases odds of a move toward S1 29.888. Upside levels are R1 34.883 then R2 36.426. Near-term pattern stats imply ~+0.27% next day, +1.7% next week, but -6.53% next month, suggesting near-term stability followed by elevated medium-term downside risk.

Latest reported quarter: 2025/Q3.
Recent trend is mixed but improving: after a bearish turn in early Dec (Wolfe downgrade to Underperform, PT 23), the tape of analyst actions shifted more constructive with Mizuho upgrading to Neutral (PT 38) in Dec and Piper Sandler upgrading to Overweight (PT 40) in Jan. UBS remains Buy (PT 42) (older but still supportive).
Wall Street pros: potential West Coast tightening into 2026, leverage to PADD 5, and valuation/re-rating potential if operational catalysts deliver. Wall Street cons: sector headwinds, margin sensitivity (distillate cracks), and execution timing (e.g., restart-related uncertainty) leading to divergent targets and ratings.